Skip to content
10-Q

Quarterly Report

SIGNPATH PHARMA, INC.

0001096906-14-000659

← back to feed
Filed
May 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · May 12, 2014 12.88M sh
Capex Q1 2014 · Mar 31, 2014 $5.39K
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$6.28M
Operating Cash Flow Q1 2014 · Mar 31, 2013 −$537.68K
Stockholders Equity Q1 2014 · Mar 31, 2014 $941.53K
Stockholders Equity Q1 2014 · Dec 31, 2013 $819.77K
Current Liabilities Q1 2014 · Mar 31, 2014 $285.71K
Current Liabilities Q1 2014 · Dec 31, 2013 $421.63K
Current Assets Q1 2014 · Mar 31, 2014 $1.23M
Current Assets Q1 2014 · Dec 31, 2013 $1.24M
Total Assets Q1 2014 · Mar 31, 2014 $1.23M
Total Assets Q1 2014 · Dec 31, 2013 $1.24M
Sga Expense Q1 2014 · Mar 31, 2014 $1.31M
Sga Expense Q1 2014 · Mar 31, 2013 $5.14K
Rd Expense Q1 2014 · Mar 31, 2014 $4.43M
Rd Expense Q1 2014 · Mar 31, 2013 $118.41K
Net Income Q1 2014 · Mar 31, 2014 −$10.87M
Net Income Q1 2014 · Mar 31, 2013 −$768.75K
Operating Income Q1 2014 · Mar 31, 2014 −$9.9M
Operating Income Q1 2014 · Mar 31, 2013 −$832.1K